Vito Quaranta

Christian Meyer, right, a graduate student in the lab of Vito Quaranta, MD, left, received the 2019 Richard Armstrong Prize for Research Excellence last week during the Vanderbilt Institute of Chemical Biology Student Research Symposium. The prize is named for the late Richard Armstrong, PhD, professor of Biochemistry and Chemistry, who died in 2015. Meyer’s winning project was titled, “A consensus framework for calculating drug synergy.” Quaranta, professor of Biochemistry and Pharmacology, directs the Vanderbilt Quantitative Systems Biology Center.
August 15, 2019

Research excellence honored

Graduate student Christian Meyer recently received the 2019 Richard Armstrong Prize for Research Excellence.

By Bill Snyder
June 8, 2018

$8.1 million grant funds new center to research highly aggressive form of lung cancer

A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.

By Bill Snyder
April 11, 2018

“Idling” cancer cells may return

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.

By Bill Snyder
March 9, 2017

Melanoma study finds new way to enhance targeted therapies

With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.

By Bill Snyder
May 5, 2016

Current cancer drug discovery method flawed: VUMC study

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.

By Leigh MacMillan
November 23, 2015

Ten Vanderbilt faculty members elected AAAS fellows

Ten members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science.

By Bill Snyder
August 16, 2012

Method may refine personalized trials for cancer therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.
By VUMC News and Communications
February 22, 2011

Protein ‘scissors’ cut path for cancer

The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds.
By Leigh MacMillan